Table of Contents

|Articles|March 1, 2004

Pharmaceutical Executive

Pharmaceutical Executive-03-01-2004

Table of Contents

External Link - article-87627.pdf

Articles in this issue

over 22 years ago

Article

DTC: European Style

over 22 years ago

Article

The Ins and Outs of EAPs

over 22 years ago

Article

Is Everyone a Target?

over 22 years ago

Article

The Push for Modern Manufacturing

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Articles in this issue

Related Content

Pharmaceutical Executive Daily: FDA Approves Subcutaneous Sarclisa Escena

FDA Pauses Release of New CRL’s Following Citizen’s Petition

FDA Approves Subcutaneous Sarclisa Escena for Multiple Myeloma

AstraZeneca Shares Drop Following Wainua’s Failed Heart Disease Trial

U.S. Supreme Court Weighs Inducement Liability Beyond FDA Carve-Out Labels

Trending on PharmExec

AstraZeneca Shares Drop Following Wainua’s Failed Heart Disease Trial

Novartis to Layoff 322 NJ Employees: Report

Pharma M&A Roundup: Chemomab Therapeutics Enters Merger Agreement with Scipher Medicine, Teva and Polpharma Biologics Enter Global Licensing Agreement

U.S. Supreme Court Weighs Inducement Liability Beyond FDA Carve-Out Labels

Pharmaceutical Executive Daily: FDA Approves Ennumo